Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.1 - $2.95 $438 - $1,177
399 Added 0.18%
220,404 $266,000
Q4 2022

Feb 14, 2023

SELL
$1.82 - $2.71 $34,332 - $51,121
-18,864 Reduced 7.9%
220,005 $442,000
Q3 2022

Nov 14, 2022

BUY
$2.5 - $4.73 $14,162 - $26,795
5,665 Added 2.43%
238,869 $597,000
Q2 2022

Aug 15, 2022

BUY
$2.86 - $6.44 $405,668 - $913,462
141,842 Added 155.25%
233,204 $891,000
Q1 2022

May 16, 2022

BUY
$5.94 - $12.09 $452,829 - $921,669
76,234 Added 503.93%
91,362 $579,000
Q3 2021

Nov 12, 2021

BUY
$10.9 - $27.63 $164,895 - $417,986
15,128 New
15,128 $169,000

Others Institutions Holding OMIC

About Singular Genomics Systems, Inc.


  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.42B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.